| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $602.1M | +30.6% |
| R&D Expense | $22.4M | -22.6% |
| SG&A Expense | $112.1M | -15.4% |
| Operating Income | -$278.0M | +3.0% |
| Pre-tax Income | -$296.6M | -79.5% |
| Income Tax | -$933K | -275.0% |
| Net Income | -$295.7M | -78.4% |
| EPS (Basic) | -$27.04 | -3280.0% |
| EPS (Diluted) | -$27.04 | -3280.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $95.8M | -61.2% |
| Accounts Receivable | $8.0M | +42.5% |
| Current Assets | $161.2M | -48.5% |
| Total Assets | $1.52B | -3.3% |
| Current Liabilities | $506.2M | +102.0% |
| Long-term Debt | $170.2M | -1.6% |
| Total Liabilities | $1.90B | +19.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$110.9M | +25.6% |
| Capital Expenditures | $10.6M | -62.5% |
| Investing Cash Flow | -$12.4M | +60.1% |
| Financing Cash Flow | -$32.2M | -108.0% |
| Free Cash Flow | -$121.5M | +31.5% |
| Stockholders' Equity |
| -$376.7M |
| -1788.5% |